Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00179998 · ClinicalTrials.gov registry record · Phase 2
Effectiveness of Pulmozyme in Infants With Cystic Fibrosis
A Phase 2 study, sponsored by Nationwide Children's Hospital.
- Completed
- Registry status
- Phase 2
- Development phase
- 24
- Enrollment target
NCT00179998 is a Phase 2 study that has completed, run by Nationwide Children's Hospital. The registered enrollment target is 24 participants.
The verdict
NCT00179998, a Phase 2 study, has completed, sponsored by Nationwide Children's Hospital.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 24 participants
- Enrollment target
Study Summary
This is a study to find out whether Pulmozyme is effective for clearing mucus from the airways of children with cystic fibrosis less than 3 ½ years of age.
Interventions
- DRUG Placebos
- DRUG Recombinant Human DNase (Pulmozyme)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2005-01 |
| Est. Completion | 2016-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00179998
The ClinicalTrials.gov registry entry for NCT00179998 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nationwide Children's Hospital, which has 188 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebos is the first listed.
NCT00179998 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00179998 about?
NCT00179998 is a clinical study titled "Effectiveness of Pulmozyme in Infants With Cystic Fibrosis". This is a study to find out whether Pulmozyme is effective for clearing mucus from the airways of children with cystic fibrosis less than 3 ½ years of age.
What is the current status of trial NCT00179998?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 24 participants. The study started on 2005-01. Estimated completion is 2016-07.
What interventions are being tested in trial NCT00179998?
The interventions under investigation include: Placebos (DRUG), Recombinant Human DNase (Pulmozyme) (DRUG).
Who is sponsoring clinical trial NCT00179998?
This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.